SPPH OTC
Spencer Pharmaceutical Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000001-0.0001
Volume250
Avg Volume231
Beta3.69
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOMaximilien Arella
Employees2
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2023-02-07
Websitespencerpharmaceutical.com
8 Faneuil Hall Marketplace
Boston, MA 02109
US
Boston, MA 02109
US
About Spencer Pharmaceutical Inc.
Spencer Pharmaceutical Inc. is dedicated to pioneering drug delivery platforms aimed at addressing neurological conditions. A core aspect of their expertise lies in the precise, controlled administration of existing therapeutic compounds for central nervous system disorders, such as Alzheimer's, Parkinson's disease, and various forms of brain cancer. Moreover, the company holds a proprietary slow-release drug delivery system, which is utilized for managing type-2 diabetes and arthritis, and holds promise for other medical applications. Its operations are predominantly located in North America and Europe. Spencer Pharmaceutical Inc. was established in 1998 and maintains its headquarters in Boston, Massachusetts.
Latest News
No recent news
Recent Insider Trades
No insider trades found